How do you decide which peptides to use for a patient
Retatrutide , developed by Eli Lilly, is a novel triple agonist that simultaneously activates three receptors: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion
Need to work out reconstitution concentrations or convert a dose into insulin-syringe units
That's made it interesting as a possible remedy for menopause symptoms such as depression, bone loss, and sexual problems
When you restore physiological levels correctly, you get real, visible improvements in skin quality, wound healing, and hair follicle health
doi: 10.1203/00006450-200008000-00016 337 BeaumontABurtonARLemonJBennettBKLloydAVollmer-ConnaU